Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms

Halpern, 1966, Inhibition of tumour growth by administration of killed Corynebacterium parvum, Nature (Lond.), 212, 853, 10.1038/212853a0 Woodruff, 1966, Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogeneic hosts, Brit. J. Cancer, 20, 345, 10.1038/bjc.1966.42 Smith, 1972, Biological effects of Corynebacterium parvum: III. Amplification of resistance and impairment of active immunity to murine tumours, Brit. J. Cancer, 26, 361, 10.1038/bjc.1972.47 Likhite, 1974, Lasting rejection of mammary adenocarcinoma cell tumors in DBA2 mice with intratumor injection of killed Corynebacterium parvum Cancer Res., 34, 341 Likhite, 1973, The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum, Int. J. Cancer, 12, 699, 10.1002/ijc.2910120317 Castro, 1974, Antitumor effects of “Corynebacterium parvum” in mice, Europ. J. Cancer, 10, 121, 10.1016/0014-2964(74)90063-2 Scott, 1974, Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection, J. nat. Cancer Inst., 53, 855, 10.1093/jnci/53.3.855 Scott, 1974, Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection, J. nat. Cancer Inst., 53, 861, 10.1093/jnci/53.3.861 Israël, 1972, Le Corynebacterium parvum dans les cancers avancés, Nouv. Presse méd., 1, 19 Halpern, 1964, Stimulation de l'activité phagocytaire du système réticuloendothélial provoquée par Corynebacterium parvum, J. reticuloendoth. Soc., 1, 77 Castro, 1974, The effect of “Corynebacterium parvum” on the structure and function of the lymphoid system in mice, Europ. J. Cancer, 10, 115, 10.1016/0014-2964(74)90062-0 O'Neill, 1973, The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses, Immunology, 24, 977 Bomford, 1974, The mechanism of inhibition by “Corynebacterium parvum” of the growth of lung nodules from intravenously injected tumour cells, Int. J. Cancer, 14, 226, 10.1002/ijc.2910140211 Olivotto, 1974, In vitro inhibition of tumor cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum, Int. J. Cancer, 13, 478, 10.1002/ijc.2910130406 Ghaffar, 1974, Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum, Brit. J. Cancer, 29, 199, 10.1038/bjc.1974.59 Reif, 1964, The AKR thymic antigen and its distribution in leukemias and nervous tissues, J. exp. Med., 120, 413, 10.1084/jem.120.3.413 Cohen, 1970, Absorption of guinea pig serum with agar, Transplantation, 10, 130, 10.1097/00007890-197007000-00027 Kedar, 1974, Cellular immuno-adsorbents: a simplified technique for separation of lymphoid cell populations, J. Immunol., 112, 1231 Evans, 1972, Macrophages in syngeneic animal tumours, Transplantation, 14, 468, 10.1097/00007890-197210000-00011 de Halleux, 1973, A simple procedure for identification of macrophages in peritoneal exudates, Brit. J. exp. Path., 54, 352 Sjöberg, 1972, Requirement for adherent cells in the primary and secondary immune response in vitro, Europ. J. Immunol., 2, 123, 10.1002/eji.1830020206 Brunner, 1968, Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and by drugs, Immunology, 14, 181 Mantovani, 1975, On the nature of blocking factors and their lymphoid target cells in an allogeneic tumor system, Europ. J. Cancer, 11, 451, 10.1016/0014-2964(75)90077-8 Mantovani, 1975, Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response, Europ. J. Cancer, 11, 537, 10.1016/0014-2964(75)90125-5 A. Mantovani, A. Vecchi and F. Spreafico, The attacker: target cell ratio and serum effects on “in vitro” cell-mediated immunity. J. nat. Cancer Inst. In press. Weiss, 1966, Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts, J. exp. Med., 124, 1039, 10.1084/jem.124.6.1039 Piessens, 1970, Facilitation of rat mammary tumour growth by BCG, Nature (Lond.), 228, 1210, 10.1038/2281210a0 Chee, 1974, Facilitation and inhibition of B16 melanoma by BCG “in vivo” and by lymphoid cells from BCG-treated mice “in vitro”, Int. J. Cancer, 14, 137, 10.1002/ijc.2910140117 Spreafico, 1975, Characterization of the immunostimulants levamisole and tetramisole, Europ. J. Cancer, 11, 555, 10.1016/0014-2964(75)90127-9 Alexander, 1971, Endotoxin and double stranded RNA render macrophages cytotoxic, Nature New Biol., 232, 76, 10.1038/newbio232076a0 Zwilling, 1974, Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (Strain BCG), J. nat. Cancer Inst., 53, 541, 10.1093/jnci/53.2.541 Hibbs, 1973, Macrophage nonimmunologic recognition: target cell factors related to contact inhibition, Science, 180, 868, 10.1126/science.180.4088.868 Scott, 1972, Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity, Cell. Immunol., 5, 459, 10.1016/0008-8749(72)90072-X Woodruff, 1973, The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum, 184, 97 Milas, 1974, Corynebacterium granulosum-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice, Cancer Res., 34, 613 Fisher, 1974, Effect of “Corynebacterium parvum” on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed, J. nat. Cancer Inst., 53, 1793 Forman, 1973, Heterogenicity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells, J. exp. Med., 137, 369, 10.1084/jem.137.2.369 Howard, 1973, Cellular mechanisms underlying the adjuvant activity of “Corynebacterium parvum”: interactions of activated macrophages with T and B lymphocytes, 101 Scott, 1972, Biological effects of the adjuvant “Corynebacterium parvum”. II. Evidence for macrophage-T-cell interaction, Cell. Immunol., 5, 469, 10.1016/0008-8749(72)90073-1 Hersey, 1973, New look at antiserum therapy of leukaemia, Nature New Biol., 244, 22, 10.1038/newbio244022a0 Zighelboim, 1974, Antibody-mediated in vivo suppression of EL4 leukaemia in a syngeneic host, J. nat. Cancer Inst., 52, 879, 10.1093/jnci/52.3.879 Allison, 1973, Effects of adjuvants on different cell types and their interactions in immune responses, 73 Perlmann, 1972, Lymphocyte-mediated cytotoxicity in vitro, Transpl. Rev., 13, 91 Greenberg, 1973, Antibody-dependent cell-mediated cytotoxicity due to a “null” lymphoid cell, Nature New Biol., 242, 111, 10.1038/newbio242111a0 Scott, 1974, Depression of delayed-type hypersensitivity by “Corynebacterium parvum”: mandatory role of the spleen, Cell. Immunol., 13, 251, 10.1016/0008-8749(74)90243-3 Frost, 1973, The relation of lymphocyte trapping to the mode of action of adjuvants, 29 James, 1974, The effect of transplanted methylcholanthrene induced fibrosarcomata and “Corynebacterium parvum” on the immune response of CBA and A/Hej mice to thymus dependent and independent antigens, Brit. J. Cancer, 29, 11, 10.1038/bjc.1974.2